This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CYAN Cyanotech (CYAN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock About Cyanotech Stock (NASDAQ:CYAN) 30 days 90 days 365 days Advanced Chart Get Cyanotech alerts:Sign Up Key Stats Today's Range$0.37▼$0.4650-Day Range$2.83▼$3.2652-Week Range$2.37▼$6.29Volume3,680 shsAverage Volume3,483 shsMarket Capitalization$3.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI. Read More Receive CYAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter. Email Address CYAN Stock News HeadlinesCyanotech Corp. trims net losses by 40% for fiscal yearJune 20, 2025 | bizjournals.comCyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025June 20, 2025 | businesswire.comWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside. | Golden Portfolio (Ad)Cyanotech Corp (CYAN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Improved ...February 14, 2025 | finance.yahoo.comQ3 2025 Cyanotech Corp Earnings CallFebruary 13, 2025 | finance.yahoo.comCyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025February 11, 2025 | finanznachrichten.deSpirulina Beverages Market and Consumer Behaviour Analysis, 2025-2030 - Prolgae Spirulina Supplies, Cyanotech Corporation, FUL Foods, Sol-Ti, and Raw Juicery Lead the Projected $61 Million MarketJanuary 21, 2025 | globenewswire.comCyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025November 13, 2024 | finanznachrichten.deSee More Headlines CYAN Stock Analysis - Frequently Asked Questions How were Cyanotech's earnings last quarter? Cyanotech Co. (NASDAQ:CYAN) posted its quarterly earnings data on Tuesday, November, 12th. The biotechnology company reported ($0.16) EPS for the quarter. The biotechnology company had revenue of $5.85 million for the quarter. Cyanotech had a negative trailing twelve-month return on equity of 44.71% and a negative net margin of 19.50%. What other stocks do shareholders of Cyanotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL). Company Calendar Last Earnings11/12/2024Today7/11/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:CYAN CIK768408 Webwww.cyanotech.com Phone(808) 326-1353Fax808-329-4533Employees95Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.27 million Net Margins-19.50% Pretax Margin-19.48% Return on Equity-44.71% Return on Assets-19.12% Debt Debt-to-Equity Ratio0.11 Current Ratio1.06 Quick Ratio0.28 Sales & Book Value Annual Sales$23.07 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$1.33 per share Price / Book0.35Miscellaneous Outstanding Shares7,160,000Free Float5,074,000Market Cap$3.29 million OptionableNot Optionable Beta-0.11 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:CYAN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.